SciSparc subsidiary NeuroThera Labs’ quantum platform completes end-to-end hybrid workflow for clinical data analytics
SPRC•Quantum platform reaches clinical-data analytics milestone
SciSparc subsidiary NeuroThera Labs said its quantum platform reached a milestone in its quantum sampling platform for clinical-trial data analytics.
The platform ran an end-to-end hybrid quantum-classical workflow in a quantum simulation environment, from secure data ingestion to interpretable clinical insights.
The development plan targets larger dataset support, quantum algorithm optimization, and performance studies for clinical research analytics.
The platform is advanced through CliniQuantum, a quantum-focused initiative majority-owned by NeuroThera at 54.01%.
